Zurueck zur Suche

Reporte zur Charge U6999AB

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

2Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
TN 1 MI 1

VAERS 2462875

SANOFI PASTEUR · HIB (ACTHIB) · Charge U6999AB

gering
Staat
TN
Alter
-
Geschlecht
F
Eingang
28.09.2022
Impfdatum
20.09.2022
Beginn
20.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Medication error No adverse event

Symptomtext

expired dose of ACTHIB was inadvertently administered with no reported adverse event; Initial information received on 20-Sep-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves Adult female patient to whom expired dose of HIB (PRP/T) VACCINE [ACT-HIB] was inadvertently administered with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. At the time of the event, the patient had ongoing Immunosuppression. Concomitant medications included PNEUMOCOCCAL VACCINE POLYSACCH 23V (PNEUMOCOCCAL VACCINE POLYSACCH 23V) and INFLUENZA VACCINE (INFLUENZA VACCINE) for Immunisation. On 20-Sep-2022, the patient received an expired dose 0.5 ml (dose 1) of suspect HIB (PRP/T) VACCINE, powder and solvent for solution for injection, strength not reported (lot U6999AB; expiry date: 23-Jul-2022) via intramuscular route in the left arm for immunization with no reported adverse event (expired product administered) (latency: on same day). Action taken : not applicable. Outcome : Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Immunosuppression
Vorgeschichte
-
Andere Medikamente
PNEUMOCOCCAL VACCINE POLYSACCH 23V; INFLUENZA VACCINE
Allergien
-
Vorherige Impfungen
-

VAERS 2387791

SANOFI PASTEUR · HIB (ACTHIB) · Charge U6999AB

gering
Staat
MI
Alter
1,0
Geschlecht
F
Eingang
24.07.2022
Impfdatum
14.07.2022
Beginn
14.07.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

received a dose of an expired ACT-HIB diluent with no reported adverse event; Initial information received on 15-Jul-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 1 years old female patient who received a dose of an expired act-hib (HIB (PRP/T) VACCINE) diluent with no reported adverse event after receiving vaccine [ACT-HIB]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13) for Immunisation; and DIPHTHERIA VACCINE TOXOID, HIB VACCINE CONJ (TET TOX), PERTUSSIS VACCINE ACELLULAR 5-COMPONENT, POLIO VACCINE INACT 3V (MRC 5), TETANUS VACCINE TOXOID (PENTACEL) for Immunisation. On 14-Jul-2022, the patient received a dose (0.25 mL to 2 mL for vaccines or 0.1 mL for TB skin test-0.5 ML) of suspect HIB (PRP/T) VACCINE (formulation, strength: unknown) lot U6999AB, expiration date: 11-Jul-2022, via intramuscular route in the left thigh as Immunization.The patient used the product for the first time. On 14-JUL-2022 the patient received a dose of an expired act-hib diluent with no reported adverse event (expired product administered) same day following the administration of HIB (PRP/T) VACCINE. Action taken was not applicable. It was not reported if the patient received a corrective treatment for the event (received a dose of an expired ACT-HIB diluent with no reported adverse event). At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-